A study has showed that melatonin suppresses the development of AD-like dermatitis in DNFB-treated NC/Nga mice, reduces total serum IgE level, and decreases IL-4 and IFN-γ production by activated CD4+ T cells [26]. The gene discussed is CD4; the disease is Alzheimer disease.